Academic Clinical Investigator Pathway

This four-year track is designed to train academic investigators in cardiology. The program begins with two years of mentored research training that is followed by two years of clinical cardiology training. Fellows maintain a continuity clinic throughout the training period.

During the first two years, fellows are paired with a mentor who is an independent investigator. Most faculty mentors are part of the Emory Clinical Cardiovascular Research Institute (ECCRI). Research performed in this pathway can encompass a broad range of areas including epidemiology, outcomes research, health services research, cardiovascular imaging, ethics, and patient-based translational research. The mentor works with the fellow to identify, develop and execute the research project and to develop funding proposals and recommendations. During the research portion of their training, fellows participate in and present work at ECCRI and national conferences. They also participate in didactic sessions focused on developing grant writing and statistical skills.

Clinical responsibilities for the first two years are limited to weekly half-day continuity clinics. Years three and four consists of supervised clinical training as per the most recent ACGME guidelines and COCATS4 recommendations. Fellows gain experience in all aspects of clinical cardiology, which includes performing inpatient and outpatient cardiac consultations and diagnostic evaluations using noninvasive (ECG and Holter monitor interpretation, exercise stress testing echocardiography, MR, CT and nuclear imaging) and invasive (cardiac catheterization) approaches. The fellows also become familiar with cardiac electrophysiologic studies and interventional cardiology. This program exceeds the requirements for cardiovascular disease board eligibility.

This track does not participate in the NRMP match. This is due to our commitment to providing the best possible research experience and mentor pairing for our trainees. We encourage applicants with questions about this aspect of the program to contact us with any questions.

Learn more about the Emory Clinical Cardiology Research Institute (ECCRI)

Program Information

Faculty Research Areas

Faculty Research Areas

Vasilis C. Babaliaros, MD

  • Interventional cardiology
  • Structural heart disease
  • Congenital heart disease

Neal Dickert, MD, PhD

  • Bioethics 
  • Decision-making and informed consent
  • Ethics of clinical research

Abhinav Goyal, MD, MHS

  • Quality of care
  • Outcomes research

Jonathan Kim, MD

  • Sports Cardiology
  • Exercise Physiology

Michael Lloyd, MD

  • Novel resuscitation methods for cardiac arrest
  • Implantable cardiac devices in adults with congenital heart disease
  • MRI and cardiac resynchronization

Kreton Mavromatis, MD

  • Coronary artery disease
  • Vascular injury / stem cells Aortic stenosis / transcatheter aortic valve replacement

Puja K. Mehta, MD, FACC, FAHA

  • Coronary endothelial, microvascular, and smooth muscle dysfunction
  • Cardiac autonomic nervous system
  • Persistent angina in women, mental-stress angina
  • Integrative cardiology

Alanna Morris, MD

  • Outcomes in patients with advanced heart failure, including LVAD and transplant patients.
  • Translational research on the role of biomarkers of oxidative stress (OS) and endothelial dysfunction in patients with heart failure, and the importance of metabolomic signatures in determining HF progression.
  • Studying the impact of non-modifiable risk factors such as race and gender that contribute to excess disease in high risk populations.

Susmita Parashar, MD, MS, MPH

  • Women and heart disease
  • Epidemiology of coronary artery disease
  • Depression and coronary artery disease
  • Cardiooncology

Arshed A. Quyyumi, MD, FACC

  • Endothelial function Regenerative medicine
  • Peripheral arterial disease Predictive medicine research

Habib Samady, MD

  • Use of coronary physiology, endothelial function testing, wall shear stress calculation, intravascular ultrasound, optical coherence tomography, and near infrared spectroscopy in the Cardiac Catherterization Laboratory to assess coronary atherosclerosis, its progression, and its effect on coronary flow after percutaneous coronary intervention
  • Calculation of macro and micro level wall shear stress of metallic and bio-absorbable stent platforms and their effect on vascular healing Validating the diagnostic value of cardiac
  • CT imaging for characterizing coronary plaque composition and vulnerability using invasive imaging as the gold standard.

Amit Shah, MD, MSCR 

  • CVD Risk Prediction and Mechanisms
  • Health Technology in CVD Assessment
  • Mental Stress andArrhythmia Risk

Leslee J. Shaw, PhD

  • Gender and ethnic differences in risk detection
  • Test accuracy, risk assessment, prognosis, clinical outcome evaluation, and cost-effectiveness of diagnostic testing in special populations

Laurence Sperling, MD

  • Preventive cardiology
  • Cardiovascular risk prediction

Viola Vaccarino, MD, PhD

  • Cardiovascular epidemiology and prevention
  • Social and behavioral determinants of cardiovascular risk
  • Stress and heart disease
  • Cardiovascular disease in women

Peter W. Wilson, MD

  • Metabolic and cardiovascular population research
  • Determinants of coronary atery disease, including projects on physical activity, obesity, diabetes mellitus, hypertension, dyslipidemia, vascular calcification, hormonal factors, inflammatory markers, and genetics
  • Metabolic factors as antecedents of diabetes mellitus with consideration of traditional factors and insulin resistance

A. Maziar Zafari, MD, PhD

  • Genetic risk assessment in cardiovascular disease
  • In-hospital cardiac arrest and CPR
  • Role of mobile technologies in heart failure management and cardiac rehabilitation
Back to Cardiovascular Fellowship homepage